Cannabidiol/hydroxychloroquine | Interleukin Related interleukin-related.com

Product Name :
Cannabidiol/hydroxychloroquine

Search keywords :
Hydroxychloroquine (sulfate)

drugId :
null

Target Vo:
Cannabinoid CB1 receptor

Target Vo Short Name :
CB1

Moa_Name:
Autophagy inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Incannex Healthcare Ltd

Active Company_Name :
Incannex Healthcare Ltd

Active Indication_Name:
Arthritis, Rheumatoid

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Phase 2 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Hsp70 1B Antibody
6X His-tag (C-terminal) Antibody (YA860)
HSD3B1 Antibody: HSD3B1 Antibody is an unconjugated, approximately 41 kDa, rabbit-derived, anti-HSD3B1 polyclonal antibody. HSD3B1 Antibody can be used for: WB, ELISA, IHC-P, IHC-F, IF expriments in mouse, rat, and predicted: human, dog, cow, horse background without labeling.

Author: Interleukin Related

Related Posts